PolyPid Ltd. - Ordinary Shares (PYPD)
3.3600
+0.0900 (2.75%)
NASDAQ · Last Trade: Jun 9th, 6:15 PM EDT
PolyPid's D-PLEX100 met all key endpoints in a Phase 3 trial, showing a 38% drop in infection or death after colorectal surgery vs. standard care.
Via Benzinga · June 9, 2025
Via Benzinga · June 9, 2025

Via Benzinga · June 5, 2025

Via Benzinga · December 26, 2024

PYPD stock results show that PolyPid beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 14, 2024

PYPD stock results show that PolyPid beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 8, 2024

Via Benzinga · July 29, 2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion.
Via Benzinga · February 14, 2024

Shares of Applied Therapeutics, Inc.
Via Benzinga · January 5, 2024

Via Benzinga · October 12, 2023

Gainers
Via Benzinga · September 27, 2023

On Thursday, 369 companies hit new 52-week lows.
Via Benzinga · October 5, 2023

Gainers
Via Benzinga · September 27, 2023

Pre-market stock movers are worth keeping track of and we're helping with the biggest winners and losers for Wednesday morning!
Via InvestorPlace · September 27, 2023

Gainers
Via Benzinga · August 18, 2023

Friday's session saw 169 companies set new 52-week lows.
Via Benzinga · September 15, 2023

On Tuesday, 74 companies achieved new lows for the year.
Via Benzinga · March 21, 2023